Dr. Parhum Namdaran, MD

Dr. Namdaran practices at Adventist Health Glendale in Glendale, California, part of Adventist Health.

Dr. Namdaran's NPI, 1952797870, was assigned on April 7, 2015. Dr. Namdaran graduated from University Of Washington School Of Medicine in 2015. Dr. Namdaran holds California license A143762.

Dr. Namdaran's primary practice is Adventist Health Glendale, at 1509 E Wilson Terrace, Glendale, CA 91206 in Los Angeles County. The practice phone is (818) 409-8202.

Dr. Namdaran's primary practice is Adventist Health Glendale in Glendale, California, part of Adventist Health. Dr. Namdaran is also affiliated with USC Verdugo Hills Hospital. The medical group on file is Adventist Health Glendale. Dmand AI also links Dr. Namdaran to 3 more hospitals, 5 medical groups, 2 group practices and clinics and 1 ambulatory surgery center, each named with a free account. Dr. Namdaran's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Namdaran practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Namdaran's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Namdaran is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Namdaran's licenses on file in 2 states: California and Utah.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Namdaran treats.

CMS data shows 2,567 Medicare services from Dr. Namdaran across 19 procedure codes in 2024, for 947 Medicare patients. Medicare paid $158,007 for them.

CMS counts 947 Medicare patients who saw Dr. Namdaran in 2024. The largest group is 75 to 84, with 320 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 72% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Namdaran's median patient age at 62, with 52% women.

In 2024, Dr. Namdaran wrote 1,111 Medicare Part D claims for 147 patients. 82% of them were for generic drugs. CMS names the drug for 926 of them, across 20 drugs with 11 or more claims each, at $112,216 in total drug cost. In 2023, CMS named 65 claims across 1 drug.

Dr. Namdaran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Namdaran as offering telehealth. CMS counts 28 procedures of coronary angioplasty and stenting by Dr. Namdaran, more than 63% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Namdaran. The most frequent topics are Arteriovenous Malformations, Gastrointestinal Hemorrhage and Heart-Assist Devices. Dr. Namdaran's most frequent co-authors are Dipanjan Banerjee, MD, Jennifer Yi-Jiun Pan, MD and Jennifer T. Pan, MD.

CMS Open Payments shows 472 general payments to Dr. Namdaran from 44 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 86% of the total. Edwards Lifesciences Corporation paid the most, $3,977.

Dmand AI lists 1 award for Dr. Namdaran.

Dr. Namdaran graduated from University Of Washington School Of Medicine in 2015.

Dr. Namdaran is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.